Rastelli Procedure in India
Get Rastelli Procedure at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Rastelli Procedure in UAE
Rastelli Procedure at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
The Rastelli Procedure is a complex open-heart surgery performed primarily in children and young adults with specific forms of congenital heart disease — notably Transposition of the Great Arteries (TGA) with a Ventricular Septal Defect (VSD) and Left Ventricular Outflow Tract Obstruction (LVOTO) — achieving long-term survival rates exceeding 85–90% at experienced congenital cardiac centers. The procedure involves anatomic repair using an intracardiac tunnel to redirect left ventricular outflow through the VSD to the aorta, combined with placement of a valved conduit between the right ventricle and the pulmonary artery, restoring physiologically correct circulation. GAF Healthcare connects international families with top-tier pediatric cardiac surgical teams in India and the UAE, offering end-to-end coordination, significant cost advantages over Western hospitals, and access to high-volume centers with JCI and NABH/DHA accreditations.
Hospital Stay: 10–16 days (including 3–5 days in Pediatric Cardiac ICU) • Total Stay in Country (Fit-to-Fly): 6–10 weeks post-surgery (international long-haul flight clearance typically at 8 weeks, subject to cardiologist assessment) • Success Rate: 85–92% long-term survival at high-volume centers; operative mortality at experienced institutions: 3–8%
What Is It?
The Rastelli Procedure addresses a triad of congenital cardiac anomalies: dextro-Transposition of the Great Arteries (d-TGA), a large Ventricular Septal Defect (VSD), and significant Left Ventricular Outflow Tract Obstruction (LVOTO) — a combination that is incompatible with long-term survival without surgical correction. In this anatomic configuration, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle; the LVOTO prevents effective arterial switching, making the standard arterial switch operation unsuitable. Without repair, systemic oxygen saturations remain critically low, progressive ventricular dysfunction occurs, and median survival without intervention is measured in months to a few years.
The physiological goal of the Rastelli repair is to establish a biventricular circulation with anatomically correct great vessel connections. The left ventricle is connected to the aorta via an intracardiac pericardial or Dacron patch tunnel routed through the VSD, while the right ventricle is connected to the pulmonary artery via an extracardiac valved conduit — historically a homograft (cryopreserved human pulmonary or aortic allograft) or a bovine jugular vein conduit (Contegra) or a xenograft-valved tube graft. The long-term Achilles heel of the procedure is conduit degeneration and stenosis, necessitating conduit reoperation or, increasingly, transcatheter pulmonary valve replacement (TPVR) using devices such as the Melody valve or SAPIEN 3 in adolescence or adulthood.
The standard of care at high-volume congenital heart centers now integrates preoperative 3D cardiac CT angiography and cardiac MRI for precise anatomic delineation, intraoperative transesophageal echocardiography (TEE) for real-time assessment of tunnel patency and conduit function, and postoperative surveillance with serial cardiac MRI to quantify right ventricular volumes and conduit gradients. Multidisciplinary teams including pediatric cardiac surgeons, congenital interventional cardiologists, cardiac anesthesiologists, and dedicated pediatric cardiac intensivists are essential for optimizing outcomes.
Candidates
• ELIGIBLE PATIENTS:
• Infants and children (most commonly aged 1–5 years, though timing is individualized) with confirmed d-TGA + large subaortic VSD + fixed or dynamic LVOTO (subpulmonary stenosis, pulmonary valve stenosis, or pulmonary atresia)
• Patients with adequate left ventricular size (LV-to-RV volume ratio assessed on cardiac MRI/CT; LV must be capable of sustaining systemic circulation)
• Patients with sufficient VSD size to allow unobstructed intracardiac tunnel construction (typically ≥50% of the aortic annulus diameter)
• Patients with Truncus Arteriosus Type I/II (as an extension of Rastelli-type repair principles with RV-PA conduit reconstruction)
• Re-operative candidates requiring conduit revision, where transcatheter options (Melody/SAPIEN TPVR) are not anatomically feasible
• REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• 2D/3D Transthoracic Echocardiography (TTE) with color Doppler: Initial anatomic and functional assessment; measurement of VSD dimensions, outflow tract gradients, ventricular volumes
• Cardiac MRI (CMR): Precise biventricular volumetry, flow quantification, assessment of pulmonary artery anatomy and branch PA stenosis
• 64-slice or higher Cardiac CT Angiography (CTA): Coronary artery mapping, conduit sizing, 3D printed model planning in complex re-operative anatomy
• Cardiac catheterization (hemodynamic study): Pulmonary artery pressure measurement, pulmonary vascular resistance calculation (Wood units), assessment of operability in older or late-presenting patients
• Complete Blood Count, Coagulation Profile (PT, aPTT, fibrinogen), Metabolic Panel, Blood Grouping & Cross-match
• Chest X-ray and Electrocardiogram (ECG)
• Genetic/chromosomal testing (Karyotype, FISH for 22q11.2 DiGeorge deletion) — highly recommended as ~30% of conotruncal defect patients carry microdeletions affecting surgical and anesthetic management
• CONTRAINDICATIONS / HIGH-RISK FACTORS:
• Severe, fixed pulmonary arterial hypertension with pulmonary vascular resistance >8 Wood units unresponsive to vasodilator challenge (Eisenmenger physiology) — precludes biventricular repair
• Inadequate LV size or mass for systemic workload (hypoplastic LV)
• Unfavorable VSD anatomy (muscular, remote, or multiple VSDs not amenable to tunnel construction)
• Active systemic infection or sepsis prior to elective repair
• Severe associated comorbidities (e.g., uncontrolled coagulopathy, extreme prematurity in neonates)
Procedure
STANDARD RASTELLI PROCEDURE (OPEN HEART — CARDIOPULMONARY BYPASS):
Performed via median sternotomy under cardiopulmonary bypass (CPB) with moderate hypothermia (25–28°C) and cardioplegic arrest. The intracardiac tunnel is constructed from autologous pericardium or a Dacron patch, creating a non-obstructive conduit from the left ventricle through the VSD to the native aortic annulus. The LVOTO is resected or bypassed. An extracardiac valved conduit — size selected based on patient BSA and expected somatic growth — is anastomosed between the right ventricular infundibulum and the main pulmonary artery. Conduit choices include: (1) Cryopreserved pulmonary homograft (gold standard for longevity and hemodynamics), (2) Contegra bovine jugular vein conduit (widely available, good intermediate-term results), (3) Carpentier-Edwards or Hancock bioprosthetic valved conduits, and (4) CorMatrix or tissue-engineered conduits (investigational). Intraoperative TEE confirms unobstructed LV-to-Ao tunnel flow, assesses residual VSD, and evaluates conduit gradient before CPB separation.
REY MODIFICATION (ANATOMIC REPAIR WITH PULMONARY AUTOGRAFT VARIANTS):
In selected centers, modifications such as the Lecompte maneuver (anterior translocation of the pulmonary bifurcation) or integration of autologous tissue reconstruction are employed to reduce conduit length and tension, potentially extending conduit longevity.
TRANSCATHETER PULMONARY VALVE REPLACEMENT (TPVR) — FOR CONDUIT DYSFUNCTION IN POST-RASTELLI PATIENTS:
As conduit stenosis or regurgitation develops over years (typically within 10–20 years of initial repair), many post-Rastelli patients are now managed with TPVR rather than reoperation. The Medtronic Melody Valve (bovine jugular vein valve crimped onto a platinum-iridium stent) and the Edwards SAPIEN 3 valve (balloon-expandable transcatheter heart valve) are deployed percutaneously via the femoral vein, avoiding repeat sternotomy. Eligibility requires conduit diameter ≥16 mm and absence of severe coronary compression risk. TPVR has demonstrated excellent 5-year freedom from reintervention (~75–85%) and represents a paradigm shift in long-term Rastelli management.
HYBRID AND STAGED APPROACHES:
In patients with borderline anatomy or significant associated lesions (e.g., branch PA stenosis), a staged strategy may be employed: initial palliative shunt (Blalock-Taussig-Thomas shunt) or PA banding followed by complete Rastelli repair at optimal weight and anatomy. Hybrid catheter-surgical approaches are increasingly used for conduit stenting as a bridge to TPVR or reoperation.
TECHNOLOGY AND ADVANCED PLANNING TOOLS:
• Patient-specific 3D-printed cardiac models (fabricated from CT/MRI data) for pre-operative surgical simulation and conduit sizing — available at select Indian and UAE centers
• Intraoperative cardiac MRI-compatible monitoring
• Near-infrared spectroscopy (NIRS) for cerebral and somatic oximetry during CPB
• Mechanical circulatory support (ECMO, Berlin Heart EXCOR pediatric VAD) on standby for high-risk cases with anticipated ventricular dysfunction
Cost of Rastelli Procedure: India vs. UAE
The Rastelli Procedure is a resource-intensive, high-complexity congenital cardiac surgery requiring dedicated pediatric cardiac surgical teams, specialized bypass equipment, and extended PCICU care. Costs vary significantly between Western countries (typically USD 80,000–200,000+) and medical tourism destinations such as India and the UAE, without any compromise in surgical quality at accredited centers. India offers the most cost-efficient option globally for this procedure — often 70–80% below US or UK pricing — while the UAE provides a premium, regionally accessible alternative for patients from the Middle East, Africa, and Central Asia. Both destinations have internationally accredited centers with documented high-volume Rastelli experience.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $8,000 – $16,000 | ~61% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $22,000 – $40,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-OPERATIVE EVALUATION (Days 1–5 after arrival):
• Day 1: GAF Healthcare coordinator receives patient, transfers to hospital; admission workup begins
• Days 1–2: Cardiologist consultation; review of prior records, echocardiograms, and imaging from home country
• Days 2–4: Dedicated pre-operative diagnostics — cardiac catheterization (if not recently performed), cardiac MRI or CT angiography, anesthesia assessment, blood cross-match, nutritional and respiratory optimization
• Day 4–5: Multi-disciplinary team (MDT) case conference; surgical plan finalized; informed consent obtained from parents/guardians; surgical date confirmed
PHASE 2 — SURGERY DAY:
• NPO (nil by mouth) from midnight prior
• Pediatric cardiac anesthesia induction; invasive arterial and central venous line placement; TEE probe insertion
• Median sternotomy; cardiopulmonary bypass (CPB) initiated; aortic cross-clamp applied; cardioplegic arrest achieved
• Intracardiac tunnel construction (LV-to-aorta via VSD patch): approximately 45–90 minutes of complex intracardiac work
• LVOTO resection as indicated
• Valved conduit (RV-to-PA) anastomosis
• CPB weaning; intraoperative TEE confirmation; chest closure with sternal wires
• Total operative time: typically 4–7 hours
• Transfer to Pediatric Cardiac ICU (PCICU)
PHASE 3 — PEDIATRIC CARDIAC ICU (Days 1–5 post-op):
• Mechanical ventilation with lung-protective strategy; typically extubated within 24–72 hours if hemodynamically stable
• Continuous monitoring: arterial line, CVP, near-infrared spectroscopy (NIRS), cardiac output monitoring
• Vasoactive support (dopamine, milrinone, epinephrine) titrated to cardiac index >2.2 L/min/m²
• Daily chest X-ray, ECG, and point-of-care echocardiography
• Chest drain management; removal when drainage <1–2 mL/kg/hour
• Anticoagulation protocol initiated (typically aspirin or low-molecular-weight heparin depending on conduit type)
• PCICU discharge criteria: stable hemodynamics off high-dose vasoactives, adequate oxygenation, extubated, tolerating feeds
PHASE 4 — STEP-DOWN WARD (Days 5–10 post-op):
• Transition to oral cardiac medications: diuretics (furosemide, spironolactone), ACE inhibitors or ARBs if ventricular dysfunction present, aspirin
• Progressive mobilization with physiotherapy
• Wound care; sternal precautions education
• Repeat echocardiogram to assess conduit gradient, tunnel patency, ventricular function
• Nutritional optimization; lactation/feeding support for infants
• Family education on home medication administration, wound care, activity restrictions, and warning signs
PHASE 5 — DISCHARGE AND IN-COUNTRY RECOVERY (Weeks 2–8):
• Hospital discharge typically at Days 10–16 post-op
• GAF Healthcare arranges serviced apartment or partner hotel near the hospital for family
• Weekly outpatient follow-up with congenital cardiologist: clinical assessment, wound check, echocardiogram
• Sternal healing assessed at 4–6 weeks; full sternal stability required before air travel
• Cardiothoracic surgeon clearance for flight: typically at 6–8 weeks post-op; final echocardiogram and clinical review mandatory
• Comprehensive discharge summary, surgical operative notes, imaging CDs, and medication plan provided for home country cardiologist
KEY RECOVERY MILESTONES:
• Extubation: 24–72 hours
• ICU discharge: Day 3–5
• Hospital discharge: Day 10–16
• Return to light daily activity (infant/child): 4–6 weeks
• Fit-to-fly (international long-haul): 6–10 weeks (surgeon/cardiologist confirmed)
• Long-term follow-up: Cardiac MRI and catheterization at 1 year; conduit surveillance every 2–3 years thereafter
Risks & Considerations
The Rastelli Procedure carries significant perioperative and long-term risks that must be transparently discussed with families prior to surgery. Operative mortality at high-volume centers is reported at 3–8%, with higher risk in patients with associated anomalies, prior palliative procedures, or pulmonary hypertension. Early post-operative complications include: low cardiac output syndrome (managed with inotropic support and, if refractory, ECMO), complete heart block requiring permanent pacemaker implantation (incidence ~5–10%, related to proximity of conduction tissue to the VSD patch), residual or recurrent VSD (requiring re-intervention in ~3–5% of cases), conduit kinking or early stenosis, and pleural or pericardial effusions. Neurological complications — including stroke and neurodevelopmental delay — are a recognized risk associated with cardiopulmonary bypass and deep hypothermic circulatory arrest, occurring in approximately 2–5% of cases; centers using NIRS and optimized CPB management protocols aim to minimize this risk. The most predictable long-term complication is conduit degeneration: virtually all biological conduits will require intervention (surgical replacement or transcatheter pulmonary valve replacement) within 10–20 years, with smaller conduits in younger patients requiring earlier revision. Patients with 22q11.2 microdeletion (DiGeorge syndrome) — present in ~25–30% of this population — face additional risks including hypocalcemia, immune deficiency, and palatal dysfunction, requiring multidisciplinary co-management. Families should be counseled that this is a palliative-to-corrective procedure requiring lifelong cardiology surveillance, and that re-intervention is the norm rather than the exception over a patient's lifetime.
Top Hospitals for Rastelli Procedure
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Apollo Hospitals
New Delhi, India
Fortis Memorial Research Institute
Gurgaon, India
Medanta - The Medicity
Gurgaon, India
Kokilaben Dhirubhai Ambani Hospital
Mumbai, India
Top Doctors for Rastelli Procedure
Internationally trained specialists in Cardiology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Krishna S Iyer
MBBS, MS (Surgery), M.Ch (Cardiothoracic Surgery), Fellowship in Infant Cardiac Surgery
Pediatric Cardiac Surgeon
Fortis Escorts Heart Institute, New Delhi, India
35+ Yearsof experience
Dr. Krishna S Iyer is one of India's most experienced and internationally recognised pediatric cardiac surgeons. As Executive Director of Pediatric and Congenital Heart Surgery at Fortis Escorts Heart Institute in Okhla, New Delhi, he has devoted his career to giving children with congenital heart disease — some of the most complex and delicate patients in all of medicine — the best possible chance at a full life. After his medical training, Dr. Iyer… Read more
Dr. Devi Shetty
MBBS, MS (General Surgery), MCh (Cardiothoracic Surgery), Fellowship in Cardiac Surgery
Cardiac Surgeon
Narayana Health, Bengaluru, India
38+ Yearsof experience
Dr. Devi Prasad Shetty is one of the most respected and widely recognised cardiac surgeons in the world. He is the founder and chairman of Narayana Health, a hospital chain that has redefined what affordable, high-quality cardiac care looks like — not only in India, but globally. Early in his career, Dr. Shetty trained at Guy's Hospital in London, one of the oldest teaching hospitals in Britain. He later served as personal physician to Mother Teresa, an… Read more
Dr. Naresh Trehan
MBBS, MS (General Surgery), Fellowship in Cardiothoracic Surgery
Cardiothoracic Surgeon
Medanta – The Medicity, Gurgaon, India
40+ Yearsof experience
Dr. Naresh Trehan is widely regarded as one of the most accomplished cardiovascular and cardiothoracic surgeons of his generation. With more than four decades of clinical practice spanning India and the United States, he has performed over 48,000 cardiac surgeries and has consistently ranked among the best heart surgeons in Asia. Born and educated in India, Dr. Trehan completed his advanced surgical training at New York University Medical Center, where he… Read more
Dr. Z S Meharwal
MBBS, MS (Surgery), MCh (Cardiothoracic Surgery), MNAMS
Cardiothoracic Surgeon
Fortis Escorts Heart Institute, New Delhi, India
30+ Yearsof experience
Dr. Z S Meharwal is part of the founding team of doctors at Fortis Escorts Heart Institute in Okhla, New Delhi, one of India's most respected cardiac centres. With more than 30 years of experience in cardiac surgery and over 30,000 surgeries to his credit — including many of the most complex heart operations performed in the country — he stands as one of the most accomplished cardiothoracic surgeons of his generation. Dr. Meharwal is a pioneer in many new… Read more
Dr. Ritwick Raj Bhuyan
MBBS, MS (Surgery), M.Ch (Cardiothoracic Surgery), Senior Registrar – CTVS, Visiting Fellowship (Heart Transplant & VAD)
Cardiothoracic Surgeon
Fortis Escorts Heart Institute, New Delhi, India
20+ Yearsof experience
Dr. Ritwick Raj Bhuyan is a Cardiothoracic and Vascular Surgeon with 20 years of working experience in high-volume cardiothoracic centres in India and Australia. Currently serving as Director of Cardio Thoracic Vascular Surgery at Fortis Escorts Heart Institute in Okhla, New Delhi, he has been associated with nearly 15,000 open heart procedures and has performed more than 7,000 open heart surgeries independently — a figure that places him among the most… Read more
Frequently Asked Questions — Rastelli Procedure
The total cost of the Rastelli Procedure in India — including surgery, cardiopulmonary bypass, valved conduit (homograft or Contegra), Pediatric Cardiac ICU stay (3–5 days), general ward stay, anesthesia, and standard post-operative medications — typically ranges from USD 8,000 to USD 16,000 at JCI and NABH-accredited centers. This represents a saving of 70–80% compared to equivalent procedures in the United States or United Kingdom (where costs routinely exceed USD 80,000–120,000). In the UAE, at JCI and DHA/DOH-accredited hospitals in Dubai and Abu Dhabi, the same procedure ranges from approximately USD 22,000 to USD 40,000, reflecting higher facility overheads, premium nursing ratios, and the regional infrastructure costs of a Gulf healthcare system. Both price ranges are estimates and can vary based on patient age, body weight, conduit selection (homografts are generally more expensive than xenograft conduits), complexity of associated lesions, duration of ICU stay, and whether re-operative surgery is involved. GAF Healthcare provides a detailed, itemized cost estimate based on each patient's specific diagnostic records before any commitment is made. Neither destination requires a deposit before the medical evaluation is complete.
Families should plan for a total in-country stay of 8 to 10 weeks following the Rastelli Procedure, though some patients may receive clearance for international air travel as early as 6 weeks post-operatively if recovery is uncomplicated. The key medical milestones that must be achieved before long-haul flight clearance are: complete sternal healing and stability (typically confirmed at 4–6 weeks), stable hemodynamics without inotropic or oxygen support, a resting oxygen saturation consistently above 94% on room air, no uncontrolled pleural or pericardial effusion, and a final outpatient echocardiogram demonstrating satisfactory conduit function and ventricular performance. The treating congenital cardiologist and surgeon jointly issue the fitness-to-fly certificate. For short-haul flights (under 3 hours), clearance may be possible at 5–6 weeks in select cases. Airlines require a medical clearance letter (MEDIF form) for patients who have undergone recent cardiac surgery; GAF Healthcare prepares this documentation in coordination with the surgical team. Families should not book return flights with fixed dates before receiving formal clearance, and should plan for travel insurance that covers medical extensions. GAF Healthcare's in-country coordinator assists with flight rebooking and accommodation extensions as needed.
At experienced, high-volume congenital cardiac centers — the type GAF Healthcare exclusively partners with in India and the UAE — the operative survival rate for the primary Rastelli Procedure is 92–97% (operative mortality of 3–8%), with outcomes closely correlated to surgical volume, institutional experience, and PCICU expertise. Long-term survival data from major series (including those published from centers such as the Mayo Clinic, Great Ormond Street Hospital, and equivalent high-volume Asian centers) show 10-year survival rates of approximately 85–90% and 20-year survival rates of 75–85%, with the primary cause of late mortality being conduit-related reinterventions and ventricular dysfunction rather than the index repair itself. The most important long-term consideration is conduit durability: virtually all patients will require conduit reintervention within 10–20 years, either via surgical conduit replacement or transcatheter pulmonary valve replacement (TPVR) using the Melody or SAPIEN 3 valve — a now well-established, minimally invasive catheter-based procedure. Freedom from any reintervention at 10 years is approximately 50–65%, while freedom from death or serious cardiac event at 10 years exceeds 80% at specialized centers. Quality of life outcomes are generally favorable: the majority of Rastelli patients reach adulthood with good functional capacity (NYHA Class I or II), can attend school normally, and participate in moderate physical activity, though lifelong cardiology surveillance with periodic cardiac MRI and catheterization is mandatory. GAF Healthcare provides patients with a structured long-term follow-up plan and telemedicine access to the treating cardiologist for ongoing remote surveillance after returning home.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides comprehensive end-to-end coordination for international families traveling for the Rastelli Procedure, recognizing that parents managing a critically ill child abroad require support that goes far beyond surgical booking.
FOR INDIA: GAF Healthcare facilitates the e-Medical Visa application for the patient and up to two attendants (parents/guardians), which is available to nationals of over 150 countries and is typically processed within 72 hours online through the Indian government portal. Our case managers prepare the complete visa support documentation package including hospital invitation letters, confirmed appointment letters, and physician referral summaries. India's e-Medical Attendant Visa allows both parents to accompany the child legally and remain for the full duration of treatment and recovery.
FOR UAE (DUBAI / ABU DHABI): The UAE offers visa-on-arrival or visa-free entry for nationals of over 50 countries; for others, GAF Healthcare coordinates a medical treatment visa through the hospital's international patient department, supported by DHA (Dubai Health Authority) or DOH (Abu Dhabi Department of Health) registered facilities. Processing typically takes 3–5 business days. UAE's geographic position — within a 4-hour flight of most of the Middle East, East Africa, South Asia, and Central Asia — makes it the preferred destination for families requiring shorter travel times.
AIRPORT TRANSFERS & IN-CITY LOGISTICS: GAF Healthcare arranges private, medically equipped (oxygen-ready) airport-to-hospital transfers for the patient. For families traveling with a critically ill or pre-operative infant, we coordinate with the receiving hospital's PCICU team to ensure seamless admission without emergency department delays. Return transfers at discharge are planned around the confirmed fit-to-fly date.
DEDICATED CASE COORDINATOR: Each family is assigned a single point-of-contact GAF Healthcare coordinator who speaks the family's native language (Arabic, Hindi, Urdu, Swahili, Russian, and others available). This coordinator manages appointment scheduling, surgical consent translation, insurance documentation, pharmacy coordination, and communication between the surgical team and the family.
ACCOMMODATION FOR ATTENDANTS: GAF Healthcare has partner agreements with serviced apartments and hotels within 500 meters to 2 kilometers of all partner hospitals, offering family-friendly accommodation with kitchenette facilities at negotiated rates (typically USD 40–80/night in India; USD 90–180/night in UAE). For families requiring extended stays of 6–10 weeks, monthly apartment rates are arranged. Hospital guest house options are also available at most Indian partner centers for parents who prefer to remain on campus during PCICU admission.
TELEMEDICINE PRE-CONSULTATION: Prior to travel, GAF Healthcare arranges a secure video consultation between the family and the designated pediatric cardiac surgeon, allowing complete case review, imaging interpretation, and surgical planning to be completed before departure — reducing total in-country stay duration and eliminating uncertainty upon arrival.
Patients Also Explore
Other treatments commonly sought by patients considering Rastelli Procedure.
Breast Cancer Treatment
Cancer Care
Lung Cancer Treatment
Cancer Care
Brain Tumor Surgery
Neurology
Deep Brain Stimulation
Neurology